Market Research Logo

Clostridium Difficile Diagnostics and Treatment Market - Global Industry Insights, and Forecast till 2025

Clostridium Difficile Diagnostics and Treatment Market - Global Industry Insights, and Forecast till 2025

Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.
Market Dynamics
Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.
Key features of the study:

This report provides in-depth analysis of clostridium difficile diagnostics and treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global clostridium difficile diagnostics and treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Abbott Laboratories, Trinity Biotech, Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global clostridium difficile diagnostics and treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the clostridium difficile diagnostics and treatment market

Detailed Segmentation:

Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

Global Clostridium Difficile Diagnostics and Treatment Market, By Geography:

North America

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

U.S.
Canada

Europe

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

By Drug       

Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab

By Diagnostic Test

Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others

By Distribution Channel:

Hospitals & Clinics
Diagnostic Laboratories
Pharmacies  

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Roche AG *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Thermo Fisher Scientific
Merck & Co., Inc.
Pfizer, Inc.
Actelion Pharmaceuticals, Inc.
Abbott Laboratories
Trinity Biotech
Summit Therapeutics
Sanofi S.A.
Novartis AG
AstraZeneca Plc

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Product Launches
Pipeline Analysis
Alternative Therapies
Point-of-Care Vs. Conventional Diagnostic Tests
Drug Resistant Clostridium Difficile Infection
4. Global Clostridium Difficile Diagnostics and Treatment Market, By Product Type, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
By Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Metronidazole
Vancomycin
Fidaxomicin
Bezlotoxumab
By Diagnostic Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Enzyme Immunoassays
Real-Time Polymerase Chain Reaction (RT-PCR)
Nucleic Amplification Tests (NAAT)
Others
5. Global Clostridium Difficile Diagnostics and Treatment Market, By Distribution Channel, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
6. Global Clostridium Difficile Diagnostics and Treatment Market, By Regions, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2016–2025
North America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
GCC
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Roche AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Actelion Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Trinity Biotech Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Summit Therapeutics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 37 market data tables and 43 figures on "Clostridium Difficile Diagnostics and Treatment Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook